期刊文献+

加减抵当汤对胰岛素抵抗大鼠肝脏组织PAI-1基因表达的影响 被引量:2

Effect of Modified Didang Decoction on PAI-1 Gene Expression in Liver in Insulin Resistance Rats
原文传递
导出
摘要 目的:探讨加减抵当汤对胰岛素抵抗大鼠肝脏组织PAI-1 mRNA表达的影响。方法:造模大鼠随机分成正常组、模型组、加减抵当汤高、中、低剂量组、罗格列酮组,用RT-PCR方法检测加减抵当汤对胰岛素抵抗大鼠肝脏组织PAI-1 mRNA表达的影响。结果:加减抵当汤高、中剂量组能明显下调胰岛素抵抗大鼠PAI-1 mRNA的表达(P<0.05和P<0.01)。结论:加减抵当汤能下调PAI-1 mRNA的表达,可能是其改善胰岛素抵抗的机理之一。 Objective:To explore the effect of modified Didang decoction on PAI-1 gene ex-pression in liver in insulin resistance rats.Methods:The insulin resistance rats were randomly divided into the control group,the model control group,the high,medium and low dosage of modified Didang decoction groups and western medicine (rosiglitazone) control group.Reverse transcriptase polymerase chain reactionwas used to observe the effect of modified Didang decoction on the PAI-1 of liver in rats.Results:Interving groups of modified Didang decoction compared with the model group ,the expression of PAI-1 mRNA in liver were reduced to varying degrees,which medium-dose group was significantly lower (P〈0.01),followed by high-dose group(P〈0.05).Conclusion:Through down-regulation on PAI-1 gene expression is possibly one of the mechanisms of modified Didang decoction in treating insulin resistance.
机构地区 浙江中医药大学
出处 《中华中医药学刊》 CAS 2010年第6期1244-1246,共3页 Chinese Archives of Traditional Chinese Medicine
基金 浙江省中医药管理局资助项目(2007CA006)
关键词 加减抵当汤 胰岛素抵抗 纤溶酶原激活物抑制剂-1 modified Didang decoction insulin resistance plasminogen activator inhibitor-1
  • 相关文献

参考文献8

  • 1薛长勇,郑子新,张荣欣,张效良,李溪雅,井上,修二.高脂肪、蔗糖膳食致肥胖的作用机理研究[J].营养学报,1999,21(1):42-47. 被引量:16
  • 2Storlien LH, Oakes ND, Pan DA, et al. Syndrome of insulin resistance in the rats: inducement by diet and amelioration with Benfluorex[ J] diabetes, 1993,42:457 - 462.
  • 3钱俊文,柴可夫.胰岛素抵抗模型形成过程的中医证候动态演变研究[J].中华中医药杂志,2006,21(7):430-432. 被引量:15
  • 4PannacciuUi N, DeMitrio V, Marina R, et al. Effect of glucose tolerance stares on PAl - 1 plasma levels in overweight and obese subjects[J]. Obes Res, 2002, 10 (8) :717 -725.
  • 5Henry M, Tregouet D A, Alessi M C, et al. Metabolic determinants are much more important than genetic polymorphisms in determining the PAl - 1 activity and antigen plasma concentrations: a family study with part of the Stanistlas cohort [ J ]. Arterioscler Thromb Vasc Biol, 1998,18:84 -91.
  • 6Tsuyoshi O, Michael F, Wilbur L, et al. Modulation of plasminogcn activator inhibitor - 1 in vivo: A new mechanism for the anti - fibrotic effect of rennin - angiotension inhibitor[ J]. Kidney Int, 1997,51 : 164 - 172.
  • 7Koistinen H A, Dusserre E, Ebeling P, et al. Subcutaneous adipose tissue expression of plasminogen activator inhibitor - 1 ( PAl - 1 ) in nondiabctic and Type 2 diabetic subjects [ J]. Diabetes Metab Res Rev ,2000 ,16 :364 - 369.
  • 8Nordt T K,Bode C,Sobel B E,et al. Stimulation in vivo of expression of intra - abdominal adipose tissue plasminogen activator inhibitor Type 1 by proinsulin [ J ]. Diabetologia, 2001,44 : 1121 -1124.

二级参考文献3

共引文献28

同被引文献86

引证文献2

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部